Translational Sciences Inc

📅 Upcoming

🕒 Recent(90d)

News

• Chutes & Ladders—Troubled CSL enlists GSK vet Deborah Waterhouse to lead
  CSL has tapped a new leader to steer it through a make-or-break period. Ironwood's CEO since 2021 is hanging up his hat. CytoDyn's new helmsman is highlighting the company's "transformational perio…
  fiercebiotech · 9d ago
• Top journal’s special issue on women’s health casts spotlight on menopause and pain
  "Highlighting a ton of open questions": Top journal's special issue on women's health examines the latest discoveries on chronic pain and menopause.
  stat · 1mo ago
• Chutes & Ladders—Longtime Takeda R&D chief to depart next June
  Takeda President of Research and Development Andy Plump, M.D., Ph.D., is leaving the company in June after twelve years in the position.
  fiercebiotech · 1mo ago
• Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls out
  The FDA’s new investigational new drug pilot program—one part of HHS’s broader clinical trial modernization initiatives—has lofty goals to expedite first-in-human trials of novel drugs, but experts…
  biospace · 3mo ago
• Opinion: The VA could help America win the biotechnology race with China
  “Together, HHS, the VA, and the DOD form a strong American innovation ecosystem — one that China and other competitors cannot easily replicate,” writes former VA Secretary David Shulkin.
  stat · 3mo ago
• De-Risking a Rare Disease Launch Starts with Precision
  Why traditional models fall short in rare disease commercialization—and what works instead.
  fiercebiotech · 4mo ago
• NIH-funded research lags in reporting sex differences, new study finds
  Fewer than half of papers published by NIH-funded researchers analyze or report their data by sex, a new study found.
  stat · 6mo ago